The Food and Drug Administration denied an emergency use authorization for fluvoxamine as a SARS-CoV-2 antiviral.
Subscribe to:
Post Comments (Atom)
< + > CIO Podcast – Episode 122: C-Suite Executive Roles with Saad Chaudhry
For the 122nd episode of the CIO podcast hosted by Healthcare IT Today, we are joined by Saad Chaudhry, CEO at Evergreen Healthcare Partner...
No comments:
Post a Comment